MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/jcm14020435

Медицинская библиотека · Journal of clinical medicine · 2025

Maternal Serum Catestatin Levels in Gestational Diabetes Mellitus: A Potential Biomarker for Risk Assessment and Diagnosis.

Vanli Tonyali Nazan, Karabay Gulsan, Arslan Burak, Aktemur Gizem, Tokgoz Cakir Betul, Seyhanli Zeynep, Demir Çendek Busra, Yilmaz Ergani Seval, Eroglu Hasan, Mermi Sumeyye, Celen Şevki

СтатьяПеревод в очереди

Аннотация

Background/

Objectives

Gestational diabetes mellitus (GDM) presents significant risks for both maternal and neonatal health, affecting fetal growth and increasing the likelihood of future diabetes mellitus (DM) development in affected women. The dysregulation of metabolic biomarkers, including catestatin, has been implicated in GDM pathophysiology. However, the clinical significance of catestatin in GDM remains poorly understood, particularly in the context of different therapeutic approaches.

Methods

This observational, prospective, and cross-sectional study was conducted to evaluate maternal serum catestatin levels in gestational diabetes mellitus (GDM) patients and healthy controls. Data were collected at a single time point during the second trimester of pregnancy (24 to 28 weeks). Participants were categorized based on their glucose tolerance and GDM management strategies (diet regulation or insulin therapy).

Results

Receiver Operating Characteristic (ROC) analysis demonstrated the diagnostic significance of serum catestatin levels in GDM, suggesting a cut-off value of >9.61 ng/mL for discriminating between women with and without GDM. However, further research is needed to elucidate the mechanistic role of catestatin in GDM and its utility in guiding therapeutic interventions.

Conclusions

Our study highlights the potential of catestatin as a biomarker for GDM risk stratification and monitoring, complementing existing diagnostic tools. Integrating metabolic biomarkers like catestatin into clinical management approaches may optimize maternal and neonatal health outcomes in GDM. However, the limitations of our study, including its cross-sectional design and sample size, underscore the need for future multicenter studies to validate our findings comprehensively.

Для цитирования: Vanli Tonyali Nazan, Karabay Gulsan, Arslan Burak, Aktemur Gizem, Tokgoz Cakir Betul, Seyhanli Zeynep, Demir Çendek Busra, Yilmaz Ergani Seval, Eroglu Hasan, Mermi Sumeyye, Celen Şevki. Maternal Serum Catestatin Levels in Gestational Diabetes Mellitus: A Potential Biomarker for Risk Assessment and Diagnosis.. Journal of clinical medicine. 2025. DOI: 10.3390/jcm14020435.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.